NL-OMON38794已完成不适用
Assessment of disease activity of ankylosing spondylitis with [18F]Fluoride PET-CT. - [18F]Fluoride PET-CT in AS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Men and women, * 18 and * 70 years of age
- •2. Diagnosis of ankylosing spondylitis according to the modified New York criteria.
- •3. The BASDAI score should be * 4.
- •4. Patients will start with anti-TNF according to clinical care.
- •5. Treatment with disease modifying anti-rheumatic drugs (DMARDS) and non-steroidal anti-inflammatory drugs (NSAIDs) is permitted, provided that there is a stable dose for at least 2 weeks prior to inclusion and during the study up to 16 weeks of follow up.
- •6. Patients must be able to adhere to the study appointments and other protocol
- •requirements.
- •7. Patients must be capable of giving informed consent and the consent must have been
- •obtained prior to the study related procedures.
排除标准
- •1. Treatment with any investigational drug within the previous 3 months.
- •2. Primary failure of anti-TNF treatment in the past.
- •3. Pregnancy or breast-feeding.
- •4. Implanted pacemaker
- •5. Renal failure with creatinine clearance < 30 ml/min
研究者
相似试验
招募中
1 期
Clinical Study on the Treatment of Ankylosing Spondylitis with Integrated Traditional Chinese and Western MedicineAnkylosing SpondylitisITMCTR2100004334Guangdong Provincial Hospital of Chinese Medicine
已完成
不适用
Clinical Trial of Osteoporosis in Ankylosing SpondylitisAnkylosing SpondylitisNCT00858819Göteborg University250
尚未招募
不适用
Yunpi Yishen Tongdu for active ankylosing spondylitis: a prospective cohort studyankylosing spondylitisITMCTR2100005056Zhejiang University of Traditional Chinese Medicine
已完成
不适用
The risk of cardiovascular disease in Ankylosing Spondylitis: A Single Center Cross-Sectional Study Evaluating The Association Between Inflammation In Ankylosing Spondylitis And Vascular InflammatioBechterew100110821000381610003216NL-OMON37301Academisch Medisch Centrum25
进行中（未招募）
不适用
Cardiovascular risk in patients with Ankylosing SpondylitisAnkylosing SpondylitisAtherosclerotic cardiovascular diseaseEUCTR2013-002860-19-NLAMC